Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy (Q46312896)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy |
scientific article |
Statements
1 reference
Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy (English)
1 reference
1 reference
1 reference
M Cocchietto
1 reference
L Zorzin
1 reference
B Toffoli
1 reference
R Candido
1 reference
M Stebel
1 reference
15 October 2008
1 reference
1 reference
34
1 reference
6 Pt 1
1 reference
587-594
1 reference
Identifiers
1 reference
1 reference